Merck Files for Approval of HPV Vaccine, GARDASIL

Following up on the previous blog entry about Merck's HPV Vaccine, the company announced yesterday that they have submitted a licensing application to the FDA. According to Reuters, "Merck is seeking a priority review from the FDA, which could mean Gardasil gets a green light within six months." In a grim testament to the medieval times in which we are living, the article also notes that: "the vaccines promise to be controversial, however, since they would be targeted largely at young girls. Both drug makers have been meeting with advocacy groups to dispel concerns that giving the shots might promote sexual activity." A slew of stories on the topic can be found on Google news.